Clinical Trials Browser

PRETEXT I Hepatoblastoma

Biliary Tract Neoplasms

Colonic Neoplasms

Colorectal Neoplasms

Anal Canal Carcinoma, Anus Neoplasms

Non functioning pancreatic endocrine tumor, Adenoma, Islet Cell, Neuroendocrine Tumors

Colorectal Neoplasms

Biliary Carcinoma

Colonic Neoplasms

Carcinoma, Hepatocellular, Liver Neoplasms

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Colorectal Adenocarcinoma

Adenocarcinoma Of Esophagus

Rectal Neoplasms

Adenocarcinoma Of Esophagus, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Neoplasms, Stomach Neoplasms

Adenocarcinoma Of Esophagus

Pancreatic Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Colorectal Neoplasms

Biliary Tract Neoplasms

Carcinoma, Hepatocellular

Stomach Neoplasms

Liver Neoplasms

Colorectal Neoplasms

Carcinoma, Hepatocellular

Adenocarcinoma, Neoplasms, Stomach Neoplasms

Colonic Neoplasms

Colonic Neoplasms

Pancreatic Neoplasms

Adenocarcinoma, Neoplasms, Stomach Neoplasms

Colorectal Neoplasms

Gastrointestinal Stromal Tumors

Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, DNA Repair-Deficiency Disorders

Carcinoma, Hepatocellular

Colorectal Neoplasms

Esophageal Squamous Cell Carcinoma

Stomach Neoplasms

Gastro-enteropancreatic neuroendocrine tumor

Carcinoma, Hepatocellular

Biliary Tract Neoplasms

Esophageal Squamous Cell Carcinoma

Carcinoma, Hepatocellular, Liver Neoplasms

Carcinoma, Hepatocellular

Adenocarcinoma, Stomach Neoplasms

Fibrosis, Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Esophageal Neoplasms

Fibrolamellar hepatocellular carcinoma, Hepatoblastoma

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Clinical Trials

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

TOPAZ-1

Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer

Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

ALASCCA

A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma.

Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer

EMERALD-2

STAR-221

Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)

SOLARIS

Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION)

HERIZON-GEA-01

TroFuse-015

PRISM-1

Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer

TOURMALINE

CheckMate 9DW

FORTITUDE-101

SIERRA

Combination With Sintilimab and XELOX+Bevacizumab as 1st Line Therapy in RAS-mutant Metastatic Colorectal Cancer

Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer

Spotlight

ECTX

Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer

Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer

GLOW

CodeBreak300

INTRIGUE

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular Carcionma

A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer

KUNLUN

XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC)

NETTER-2

Camrelizumab, Apatinib Plus HAIC Versus Camrelizumab and Apatinib for HCC With Portal Vein Invasion: a Randomized Trial

AK112 Combined With Chemotherapy Versus Durvalumab Combined With Chemotherapy in Advanced Biliary Tract Cancer

SKYSCRAPER-07

EMERALD-1

HIMALAYA

Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)

SACRED

SKYSCRAPER-14

A Study to Evaluate Camrelizumab Plus Rivoceranib (Apatinib) as Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation

ESO-Nanjing7

Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery

SOLSTICE